Free Disclosure Statement - District Court of Delaware - Delaware

Case 1:08-cv-00359-JJF-LPS

Document 5

Filed 01/31/2008

Page 1 of 2

Arnold B. Calmann ([email protected]) Jane Jhun ([email protected]) SAIBER LLC One Gateway Center 13th Floor Newark, NJ 07102-5311 Tel: 973.622.3333 Fax: 973.622.3349 Of Counsel: Jeffrey S. Ward ([email protected]) Thomas P. Heneghan ([email protected]) Shane A. Brunner ([email protected]) Edward J. Pardon ([email protected]) MICHAEL BEST & FRIEDRICH LLP One South Pinckney Street P.O. Box 1806 Madison, WI 53701-1806 Tel: 608.257.3501 Fax: 608.283.2275 Attorneys for Defendants Aurobindo Pharma Limited and Aurobindo Pharma USA, Inc. UNITED STATES DISTRICT COURT FOR THE DISTRICT OF NEW JERSEY ASTRAZENECA PHARMACEUTICALS LP,) ) ASTRAZENECA UK LIMITED, ) IPR PHARMACEUTICALS, INC., and ) SHIONOGI SEIYAKU KABUSHIKI ) KAISHA, ) Plaintiffs, ) ) v. ) ) AUROBINDO PHARMA LIMITED, and ) AUROBINDO PHARMA USA, INC., ) ) Defendants. ) ) Case No. 07-CV-06020 (MLC)(JJH) DEMAND FOR JURY TRIAL AUROBINDO PHARMA LIMITED, AND AUROBINDO PHARMA USA, INC.'S DISCLOSURE PURSUANT TO FED. R. CIV. P. 7.1 DOCUMENT ELECTRONICALLY FILED

Case 1:08-cv-00359-JJF-LPS

Document 5

Filed 01/31/2008

Page 2 of 2

Pursuant to Fed. R. Civ. P. 7.1(a), Defendants state that Aurobindo Pharma Limited, a publicly-held company, is the ultimate parent company of Aurobindo Pharma USA, Inc. No other publicly-held corporation owns 10% or more of the stock of Aurobindo Pharma Limited and Aurobindo Pharma USA, Inc.

Dated: January 31, 2008.

Respectfully submitted, SAIBER, LLC Attorneys for Defendants Aurobindo Pharma Limited and Aurobindo Pharma USA, Inc. /s/ Arnold B. Calmann Arnold B. Calmann Jane Jhun One Gateway Center 13th Floor Newark, NJ 07102-5311 Tel: 973.622.3333 Fax: 973.622.3349 [email protected] [email protected] Of Counsel: Jeffrey S. Ward Thomas P. Heneghan Shane A. Brunner Edward J. Pardon MICHAEL BEST & FRIEDRICH LLP One South Pinckney Street P.O. Box 1806 Madison, WI 53701-1806 Tel: 608.257.3501 Fax: 608.283.2275 [email protected] [email protected] [email protected] [email protected]